Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript

Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.

Related Keywords

France ,French ,Sumant Kulkarni ,Neil Mcfarlane ,Christal Mickle ,Jonathan Aschoff ,Oren Livnat ,Laduane Clifton ,Joshua Schafer ,Nichol Ochsner ,Corporate Communications For Zevra Therapeutics ,Drug Enforcement Administration ,Business Development ,Unidentified Company Representative ,Zevra Therapeutics Inc ,Nasdaq ,Innovation Mc Group ,Zevra Therapeutics ,Call Transcript March ,Financial Results ,Vice President ,Investor Relations ,Corporate Communications ,Zevra Therapeutic ,Investor Release ,Risk Factors ,Chief Executive Officer ,Chief Financial Officer ,Chief Commercial Officer ,Chief Development Officer ,Adrian Quartel ,Chief Medical ,Nowi Ll ,Quick Start ,Drug Enforcement ,Epworth Sleepiness Scale ,Duane Clifton ,Most Fluoridated Water ,Smelling Essential Oils ,Company Representative ,